Search

everythinglearnresearchcommunity

for

Search:↓

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Overexpressing thrombospondin-1 in mice skin prevents UVB-induced skin damage.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Short-chain fatty acids from *Cutibacterium acnes* cause skin inflammation, contributing to acne.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Skin tumor regression is helped by retinoic acid signaling blocking Wnt signaling.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Entospletinib effectively prevents eye and skin GVHD in mice.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

17β-Estradiol slows wound healing in male mice through estrogen receptor-α.

Ruxolitinib can help regrow hair in severe alopecia areata.

Hair loss requires customized treatments based on its various causes and types.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Combined arsenic and low oxygen stress alters root growth to help plants absorb nutrients.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.